Table 3.
Patient Characteristics
| Characteristic | # of infusions | # of infusions with at least one event | % of infusions with at least one event | Odds Ratio | p/value* |
|---|---|---|---|---|---|
|
| |||||
| Age | |||||
| <70 years | 634 | 67 | 10.6 | Reference | 0.9077 |
| >70 years | 37 | 4 | 10.8 | 1.06 (0.37, 3.02) | |
|
| |||||
| Race | |||||
| white | 645 | 68 | 10.5 | Reference | 0.8716 |
| non-white | 26 | 3 | 11.5 | 1.10 (0.35, 3.50) | |
|
| |||||
| Gender | |||||
| female | 272 | 33 | 12.1 | Reference | 0.3817 |
| male | 399 | 38 | 9.5 | 0.79 (0.47, 1.33) | |
|
| |||||
| Number of existing allergies | 0.0264** | ||||
| none | 333 | 25 | 7.5 | Reference | |
| one or two | 268 | 39 | 14.6 | 2.13 (1.23, 3.70) | 0.0072*** |
| >2 allergies | 70 | 7 | 10 | 1.35 (0.58, 3.17) | 0.4876 |
|
| |||||
| Ferumoxytol dose | 0.4036** | ||||
| ≤ 2mg/kg | 121 | 8 | 6.6 | Reference | |
| 2–4 mg/kg | 303 | 34 | 11.2 | 1.77 (0.69, 4.54) | 0.2340 |
| >4 mg/kg | 247 | 29 | 11.7 | 1.86 (0.75, 4.58) | 0.1787 |
|
| |||||
| Steroid use | |||||
| None | 461 | 44 | 9.5 | Reference | 0.1263 |
| on decadron | 183 | 25 | 13.7 | 1.56 (0.92, 2.67) | |
|
| |||||
| Pathology | |||||
| Non-tumor | 5.4 | 5 | 9.3 | Reference | 0.7069. |
| tumor | 617 | 66 | 10.7 | 1.20 (0.47, 3.04) | |
P-value are obtained from the logistic generalized estimating equation model.
Overall P-value for the number of existing allergies, or Ferumoxytol dose.